Literature DB >> 7017182

Clinical applicability of a methacholine inhalational challenge.

J R Myers, W M Corrao, S S Braman.   

Abstract

Cough, dyspnea, and chest pain are symptoms common to many cardiopulmonary diseases. A comprehensive evaluation, including a history, physical examination, ECG, chest roentgenogram, and pulmonary function studies, will often yield a specific diagnosis. However, when these symptoms are intermittent, as they often are in patients with bronchial asthma, the diagnosis may not be apparent. If asthma is thought to be a diagnostic possibility, a bronchial inhalation challenge should be used to demonstrate bronchial hyperreactivity, the hallmark of asthma. The methacholine chloride inhalation challenge is a simple and useful laboratory test to diagnose bronchial hyperreactivity. We describe eight patients with a variety of clinical symptoms to demonstrate the usefulness of this test. Patients with unexplained respiratory symptoms should be considered for bronchial inhalation challenge before proceeding to more invasive diagnostic procedures.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7017182

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  3 in total

1.  Chest tightness variant asthma (CTVA): reconfirmed and not generally appreciated.

Authors:  Richard S Irwin
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

Review 2.  Drug treatment of asthma in the elderly.

Authors:  S S Braman
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

3.  Proteomic analysis of sputum reveals novel biomarkers for various presentations of asthma.

Authors:  Chao Cao; Wen Li; Wen Hua; Fugui Yan; Hao Zhang; Huaqiong Huang; Yinghua Ying; Na Li; Fen Lan; Shaobin Wang; Xiao Chen; Jing Li; Jinkai Liu; Tianwen Lai; Zhengqiang Bao; Yuan Cao; Yun Zhao; Gang Huang; Lili Huang; Yaqing Huang; Ping Wu; Chao Peng; Zhihua Chen; Kian Fan Chung; Nanshan Zhong; Songmin Ying; Huahao Shen
Journal:  J Transl Med       Date:  2017-08-04       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.